CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Similar to the findings with somatic CML CD34+ cells (Leng et al. 2013; Li and Dewey 2011), untreated CML iCD34+ cells showed significant differences compared to normal BM iCD34+ cells in the expression of genes regulating chemotaxis, adhesion, cytokine production, proliferation, programmed cell death, regulation of phosphorylation, and fatty acid metabolism (Supplementary Fig. S3a).